NCT05408104View on ClinicalTrials.gov

Postoperative Tolvaptan Use in Left Ventricular Assist Device Implantation Patients

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

March 28, 2019

Primary Completion Date

May 1, 2022

Study Completion Date

May 1, 2022

Conditions
Heart FailureHeart Assist DeviceHyponatremic
Interventions
DRUG

tolvaptan

LVAD recipients with post-operative hyponatremia (Na \< 135 mEq/L). Subjects took tolvaptan 15 mg daily as part of their standard care.

Trial Locations (1)

60637

University of Chicago Medical Center, Chicago

All Listed Sponsors
lead

University of Chicago

OTHER

NCT05408104 - Postoperative Tolvaptan Use in Left Ventricular Assist Device Implantation Patients | Biotech Hunter | Biotech Hunter